Search - tctmd.com

Displaying 241 - 260 of 8325

Sort: Relevancy | Date

Presentation TCT 2016

Debate: Should Complete Revascularization in STEMI and Multivessel Disease Be Performed During the Index Procedure? No, in the Middle of the Night and With Complex Anatomy ... Are You Kidding?!

Presenter: Adrian P. Banning, Nick Curzen, Herbert D. Aronow

November 01, 2016

Presentation TCT 2016

Put Away Your Catheters! Nanomedicines to Treat Vulnerable Plaque

Presenter: Gregg W. Stone, Ron Waksman, Jonathan Leor

November 01, 2016

Presentation TCT 2016

CT For Procedural Planning in CTO and Complex Coronary Interventions

Presenter: Jeroen J. Bax, Jonathon A. Leipsic, James K. Min, Farouc Jaffer

November 01, 2016

Presentation TCT 2016

The Case for Transcatheter Therapy

Presenter: Michael A. Borger, Vinod H. Thourani, Josep Rodés-Cabau

November 01, 2016

Presentation TCT 2016

Return Fire: The Contrarian View - Bioresorbable Scaffolds Provide Meaningful Value for Most Patients Undergoing PCI!

Presenter: Sanjay Kaul, Jeffrey J. Popma, Michael Haude

November 01, 2016

Presentation TCT 2016

The Case for Multivessel PCI

Presenter: John A. Bittl, David J. Maron, Sripal Bangalore

November 01, 2016

News Conference News TCT 2016

ReACT: Routine Angiographic Follow-up After PCI Does Not Lower Clinical Events

Michael O'Riordan

November 01, 2016

Presentation TCT 2016

DCB for De Novo Lesions: Clinical Applications and Technical Pitfalls

Presenter: Fernando Alfonso, Juan F. Granada, Bernardo Cortese

November 01, 2016

Presentation TCT 2016

Are PCSK9 Inhibitors and Anti-inflammatory Therapies for Vulnerable Plaque Right Around the Corner?

Presenter: Gregg W. Stone, Ron Waksman, Sanjit S. Jolly

November 01, 2016

Presentation TCT 2016

Integrated Anatomical and Functional Assessment of Coronary Artery Stenosis

Presenter: Jeroen J. Bax, Jonathon A. Leipsic, James K. Min, Manesh R. Patel

November 01, 2016

Presentation TCT 2016

Opening Salvo: I Don't Believe Bioresorbable Scaffolds Provide Meaningful Value for Most Patients Undergoing PCI!

Presenter: Sanjay Kaul, Jeffrey J. Popma, Salvatore Cassese

November 01, 2016

Presentation TCT 2016

The Case for CABG

Presenter: John A. Bittl, David J. Maron, A. Pieter Kappetein

November 01, 2016

Presentation TCT 2016

To Treat or Not to Treat (Focally): From Stable to PROSPECT-ABSORB and PREVENT

Presenter: Gregg W. Stone, Ron Waksman, Seung-Jung Park

November 01, 2016

Presentation TCT 2016

Understanding FFRct

Presenter: Jeroen J. Bax, Jonathon A. Leipsic, James K. Min

November 01, 2016

Presentation TCT 2016

Debate- Is Upper Extremity Dysfunction After Radial Access Frequent and Clinically Important? No, Much Ado About Nothing!

Presenter: Adrian P. Banning, Nick Curzen, Samir B. Pancholy

November 01, 2016

Presentation TCT 2016

The Case for a Trial of Medical Therapy

Presenter: John A. Bittl, David J. Maron, Michael E. Farkouh

November 01, 2016

Presentation TCT 2016

Debate- Is Upper Extremity Dysfunction After Radial Access Frequent and Clinically Important? Yes, We Have to Start Paying Attention to This Phenomenon!

Presenter: Adrian P. Banning, Nick Curzen, Robert-Jan van Geuns

November 01, 2016

Presentation TCT 2016

Bioresorbable Scaffolds for Vulnerable Plaque Treatment: Rationale for Focal Therapy, Early Clinical Experiences, and Will it Succeed?!

Presenter: Gregg W. Stone, Ron Waksman, Vasim Farooq

November 01, 2016

Presentation TCT 2016

DEBATE: DCB for In-Stent Restenosis: Does the Current Data Support Broad Adoption? Yes! The Data is Solid and DCB Should be the Treatment of Choice!

Presenter: Fernando Alfonso, Juan F. Granada, Bruno Scheller

November 01, 2016

Presentation TCT 2016

CT for Automated Quantification of Coronary Artery Stenosis

Presenter: Jeroen J. Bax, Jonathon A. Leipsic, James K. Min, Paul Knaapen

November 01, 2016

Advertisement

Debate: Should Complete Revascularization in STEMI and Multivessel Disease Be Performed During the Index Procedure? No, in the Middle of the Night and With Complex Anatomy ... Are You Kidding?!

Put Away Your Catheters! Nanomedicines to Treat Vulnerable Plaque

CT For Procedural Planning in CTO and Complex Coronary Interventions

The Case for Transcatheter Therapy

Return Fire: The Contrarian View - Bioresorbable Scaffolds Provide Meaningful Value for Most Patients Undergoing PCI!

The Case for Multivessel PCI

ReACT: Routine Angiographic Follow-up After PCI Does Not Lower Clinical Events

DCB for De Novo Lesions: Clinical Applications and Technical Pitfalls

Are PCSK9 Inhibitors and Anti-inflammatory Therapies for Vulnerable Plaque Right Around the Corner?

Integrated Anatomical and Functional Assessment of Coronary Artery Stenosis

Opening Salvo: I Don't Believe Bioresorbable Scaffolds Provide Meaningful Value for Most Patients Undergoing PCI!

The Case for CABG

To Treat or Not to Treat (Focally): From Stable to PROSPECT-ABSORB and PREVENT

Understanding FFRct

Debate- Is Upper Extremity Dysfunction After Radial Access Frequent and Clinically Important? No, Much Ado About Nothing!

The Case for a Trial of Medical Therapy

Debate- Is Upper Extremity Dysfunction After Radial Access Frequent and Clinically Important? Yes, We Have to Start Paying Attention to This Phenomenon!

Bioresorbable Scaffolds for Vulnerable Plaque Treatment: Rationale for Focal Therapy, Early Clinical Experiences, and Will it Succeed?!

DEBATE: DCB for In-Stent Restenosis: Does the Current Data Support Broad Adoption? Yes! The Data is Solid and DCB Should be the Treatment of Choice!

CT for Automated Quantification of Coronary Artery Stenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content